Search Within

Neil Jayendra Shah

Formats
  1. Meeting Abstract (53)
  2. Journal Article (27)
  3. Conference Paper (1)
  4. Editorial (1)
  5. Research Letter (1)
Groups
  1. Department of Medicine (83)
  2. Genitourinary Oncology Service (83)
  3. Solid Tumor Oncology Division (83)
  4. Hematologic Malignancies, Division of (31)
  5. Weinberg Fellows (31)
  6. Population Sciences Research Program (25)

More Groups

People
  1. Robert Motzer (37)
  2. Ritesh Kotecha (26)
  3. Martin Voss (25)
  4. Maria Carlo (22)
  5. Darren Feldman (21)
  6. Chung-Han Lee (20)

More People

Years
  1. 2025 (8)
  2. 2024 (19)
  3. 2023 (22)
  4. 2022 (18)
  5. 2021 (13)
  6. 2020 (2)

More Years

Publications
  1. Journal of Clinical Oncology (44)
  2. Journal for ImmunoTherapy of Cancer (7)
  3. Cancers (4)
  4. The Oncologist (3)
  5. Annals of Oncology (2)
  6. Cancer (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (46)
  2. Biomed Central Ltd (7)
  3. Oxford University Press (6)
  4. MDPI (5)
  5. American Association for Cancer Research (3)
  6. American Medical Association (2)

More Publishers

Results (83)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The risk of opportunistic infections and the role of antibiotic prophylaxis in patients on checkpoint inhibitors requiring steroids
    Journal Article

    Shah, N. J.; Cook, M. R.; Wu, T.; Lev-Ari, S.; Blackburn, M. J.; Serzan, M. T.; Alaoui, A.; Ahn, J.; Atkins, M. B.
    Journal of the National Comprehensive Cancer Network (2022)

    Fulltext@MSK | Save
  • Contribution of the skin–gut axis to immune-related adverse events with multi-system involvement
    Journal Article

    Kuo, A. M.; Kraehenbuehl, L.; King, S.; Leung, D. Y. M.; Goleva, E.; Moy, A. P.; Lacouture, M. E.; Shah, N. J.; Faleck, D. M.
    Cancers (2022)

    Fulltext@MSK | Save
  • The impact of androgen deprivation therapy on COVID-19 illness in men with prostate cancer
    Journal Article

    Shah, N. J.; Patel, V. G.; Zhong, X.; Pina, L.; Hawley, J. E.; Lin, E.; Gartrell, B. A.; Adorno Febles, V.; Wise, D. R.; Qin, Q.; more...
    JNCI Cancer Spectrum (2022)

    Fulltext@MSK | Save
  • Real-world assessment of changing treatment patterns and sequence for patients with metastatic renal cell carcinoma (mRCC) in the first-line (1L) setting
    Meeting Abstract

    Shah, N. J.; Sura, S.; Shinde, R.; Shi, J.; Perini, R. F.; Puneet, S.; Robert, N. J.; Vogelzang, N. J.; Motzer, R. J.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Real-world clinical outcomes of patients (pts) with metastatic renal cell carcinoma (mRCC) in current immune-oncology (IO) and tyrosine kinase inhibitors (TKIs) era
    Meeting Abstract

    Shah, N. J.; Sura, S.; Shinde, R.; Shi, J. X.; Perini, R. F.; Puneet, S.; Robert, N. J.; Vogelzang, N. J.; Motzer, R. J.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Incidence and clinical outcomes of HER2-altered bladder cancer (BC) patients (pts)
    Meeting Abstract

    Lattanzi, M.; Niederhausern, A.; Zheng, J.; Bahadur, N.; Nichols, C.; Barton, L.; Gandhi, F.; Chan, K.; Insinga, A.; Philip, J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase II study of talazoparib and avelumab in VHL deficient clear cell renal cell carcinoma
    Meeting Abstract

    Kotecha, R.; Lee, C. H.; McHugh, D. J.; Dadoun, C.; Knezevic, A.; Carlo, M. I.; Feld, E.; Shapnik, N.; Shah, N. J.; Feldman, D. R.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A phase 1b/2 randomized study of Avb-S6-500 in combination with cabozantinib versus cabozantinib alone in patients with advanced clear cell renal cell carcinoma who have received front-line treatment
    Meeting Abstract

    Beckermann, K.; Vogelzang, N.; Shifeng, M.; Ornstein, M.; Shah, N.; Hammers, H.; Campbell, M.; Gao, X.; McDermott, D.; Anderson, R.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Germline variants identified in patients with early-onset renal cell carcinoma referred for germline genetic testing
    Journal Article

    Truong, H.; Sheikh, R.; Kotecha, R.; Kemel, Y.; Reisz, P. A.; Lenis, A. T.; Mehta, N. N.; Khurram, A.; Joseph, V.; Mandelker, D.; more...
    European Urology Oncology (2021)

    Fulltext@MSK | Save
  • Association between body mass index and immune‐related adverse events (IrAEs) among advanced‐stage cancer patients receiving immune checkpoint inhibitors: A pan‐cancer analysis
    Journal Article

    Zhang, D.; Shah, N. J.; Cook, M.; Blackburn, M.; Serzan, M. T.; Advani, S.; Potosky, A. L.; Madhavan, S.; Belouali, A.; Atkins, M. B.; more...
    Cancers (2021)

    Fulltext@MSK | Save